½ÃÀ庸°í¼­
»óǰÄÚµå
1684056

ÀÇ·á±â±â¿ë MLCC ½ÃÀå : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Medical Devices MLCC - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á±â±â¿ë MLCC ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 11¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2029³â¿¡´Â 32¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£(2024-2029³â) Áß CAGR 23.06%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

Medical Devices MLCC-Market-IMG1

ÁøÈ­ÇÏ´Â ÀÇ·á±â±â¿¡¼­ MLCCÀÇ ¿µÇâ·ÂÀÌ ³ô¾ÆÁý´Ï´Ù.

  • ¼¼°èÀÇ ÀÇ·á±â±â¿ë MLCC ½ÃÀåÀº ÇコÄɾî ÁöÃâ Áõ°¡ ¹× ¼±Áø ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä¿¡ °ßÀεǾî Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÄÉÀ̽º »çÀÌÁî¿¡ µû¶ó ±¸ºÐµÇ¸ç, ÁÖ¿ä »çÀÌÁî´Â ¸íÈ®ÇÑ ±â¼úÀû Áøº¸¸¦ Á¦°øÇÏ¸ç Æ¯Á¤ ÀÇ·á ¿ä±¸¸¦ ÃæÁ·ÇÕ´Ï´Ù.
  • 0 402 MLCC´Â ¼ÒÇüÀ̸鼭 ´ë¿ë·®À̹ǷΠÃÖ÷´Ü ÀÇ·á±â±â¿¡ ÇʼöÀûÀÎ ºÎǰÀÔ´Ï´Ù. ¸¸¼º Áúȯ °ü¸®, ȯÀÚ °Ç°­ ÁõÁø, ÇコÄɾî Çõ½ÅÀÇ ÃßÁø¿¡ À־ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °üÀý¿°°ú ¾Ï°ú °°Àº ¸¸¼º Áúȯ Áõ°¡´Â 0 603 MLCC ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÎǰÀº Á¶±â ¹ß°ß°ú Á¤È®ÇÑ Áø´ÜÀ» À§ÇØ MRI ¹× CT ½ºÄµÀ» ¼öÇàÇÏ´Â Àåºñ¿¡ ÇʼöÀûÀÔ´Ï´Ù.
  • AI¸¦ žÀçÇÑ ÀÇ·á¿ë ·Îº¿ ¹× ¿þ¾î·¯ºí ÀÇ·á¿ë ¼¾¼­ÀÇ ÃâÇöÀÌ, 0 805 MLCC ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÎǰÀº ÀÇ·á±â±âÀÇ AI¿Í ·Îº¿ ±â´É¿¡ Àü·ÂÀ» °ø±ÞÇÏ°í ¼ö¼ú ·Îº¿°ú ÀçȰ ·Îº¿ÀÌ ±× µ¿ÇâÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. 1 206 MLCC´Â AI ÁÖµµ Áø´Ü µµ±¸ ¹× ¿þ¾î·¯ºí ÀÇ·á ¼¾¼­¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¾ÏÀ̳ª ½É¹æ¼¼µ¿°ú °°Àº ÁúȯÀÌ °è¼Ó È®»êµÇ´Â °¡¿îµ¥ Á¤È®Çϰí È¿À²ÀûÀÎ Áø´ÜÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù.
  • ƯÁ¤ ÀÇ·á¿ë ÀÓÇöõÆ®ÀÇ ¿ä±¸¿¡ ´ëÀÀÇÏ´Â °úÁ¤¿¡¼­ 1 210 MLCC´Â Àα¸ ¿ªÇÐ º¯È­ ¹× ¹Ì¿ë ½Ã¼ú¿¡ ÀÇÇØ ÃßÁøµÇ´Â ÀÇ·á¿ë ÀÓÇöõÆ®ÀÇ ´Ù¾çÇÑ »óȲ°ú ÀÏÄ¡ÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­ ¹× ¹Ì¿ë ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ư¼ö ÀÇ·á¿ë ÀÓÇöõÆ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´Ù¸¥ ÄÉÀ̽º »çÀÌÁî ºÎ¹®Àº ÁøÈ­ÇÏ´Â ÀÇ·á ±â¼ú¿¡ ÀûÀÀÇÏ°í ¸íÈ®ÇÑ ÀåÄ¡ ¼³°è ¹× °ø°£ Á¦¾àÀ» Áö¿øÇÕ´Ï´Ù.

ÀÇ·á±â±âÀÇ ±â¼ú Çõ½ÅÀº ´ë·úÀ» ³Ñ¾î MLCCÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄÉ¾î ½ÃÀå¿¡¼­ Å« ºñÁî´Ï½º ±âȸ¿¡ ÈûÀÔ¾î ÀÇ·á±â±â »ê¾÷ÀÇ ¿ªµ¿ÀûÀÎ Çãºê·Î µîÀåÇß½À´Ï´Ù. ¼¼°è ½ÉÀ庴 ºÎ´ãÀÇ 60%¸¦ Â÷ÁöÇÏ´Â Àεµ´Â ÀÇ·á±â±â Á¦Á¶ ´É·ÂÀ» È®¸³Çϱâ À§ÇØ 420¾ï ´Þ·¯¸¦ ÅõÀÚÇÏ¿© ÀϺ»°úÀÇ Çù·ÂÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÆÄÆ®³Ê½ÊÀº ȯÀÚ ¸ð´ÏÅÍ ¹× ½ÉÀå Ä«Å×ÅÍ¿Í °°Àº ÷´Ü Àåºñ Á¦Á¶¿¡¼­ MLCCÀÇ È°¿ë°ú ÀÏÄ¡ÇÕ´Ï´Ù.
  • ºÏ¹ÌÀÇ ÇコÄÉ¾î »çÁ¤Àº ½ÉÀ庴À̳ª ³úÁ¹Áß µî ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ Å« °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. MLCC´Â ÀÌ·¯ÇÑ ¹®Á¦¿¡ ´ëÀÀÇÏ´Â ÄÄÆÑÆ®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÀÇ·á±â±â¸¦ »ý»êÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¼ö¹é¸¸ ¸íÀÇ ¹Ì±¹ÀεéÀÌ ¸¸¼º ÁúȯÀ» ¾Î°í »ýȰÇϱ⠶§¹®¿¡ MLCC¸¦ ÅëÇÕÇÑ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½ÃŰ´Â µ¥ MLCC°¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â °ÍÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù.
  • À¯·´¿¡¼­ °¡Àå Å« ÇコÄÉ¾î ½ÃÀåÀº ³ëÈ­ ¹× ¸¸¼º Áúȯ Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. MLCC¸¦ žÀçÇÑ ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ´ç´¢º´À̳ª ½ÉÇ÷°ü Àå¾Ö¿Í °°Àº ÁúȯÀÇ °ü¸®¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­µÈ ÄÄÆ÷³ÍÆ® ¼ö¿ä´Â MLCCÀÇ ´É·Â°ú ÀÏÄ¡ÇÏ¿© Àü·Â °ü¸® ¹× ¹«¼± ¿¬°áÀ» À§ÇØ ¿þ¾î·¯ºí Àåºñ·ÎÀÇ ÅëÇÕÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.
  • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)¸¦ Æ÷ÇÔÇÑ ¼¼°è ±âŸ Áö¿ª(RoW)¿¡´Â ±âȸ¿Í µµÀüÀÌ ÀÖ½À´Ï´Ù. MEA Áö¿ªÀº ÀÇ·á±â±â¿Í ÀǾàǰ¿¡ Å« ÀáÀç·ÂÀ» º¸¿©ÁÝ´Ï´Ù. Áßµ¿ÀÇ ÇコÄÉ¾î ºÎ¹®Àº ÀÇ·á±â¼ú ¹× ÀǾàǰ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¿øµ¿·ÂÀ¸·Î 2026³â±îÁö 4,080¾ï AEDÀÇ ¼öÀÍ¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. MLCC¸¦ Æ÷ÇÔÇÑ °ÍÀ» Æ÷ÇÔÇÑ ¼±Áø ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ¾î, ÀÌ Áö¿ªÀÇ ÇコÄɾî È®´ë ¹× ±â¼ú Áß½ÃÀÇ ÀÚ¼¼¿¡ ÇÕÄ¡Çϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÀÇ·á±â±â¿ë MLCC ½ÃÀå µ¿Çâ

ÀÇ·á »ç¹° ÀÎÅÍ³Ý º¸±Þ ¹× ÀåºñÀÇ ±â¼ú Áøº¸°¡ ÇコÄɾî ÁöÃâ ÃËÁø

  • ÇコÄÉ¾î ¾÷°è´Â Çõ½ÅÀûÀÎ ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ Ã¤¿ë È®´ë µî ÇöÀúÇÑ ±â¼ú Áøº¸¸¦ °æÇèÇϰí ÀÖÀ¸¸ç, MLCC¿¡ ÀÖ¾î À¯¸ÁÇÑ ½ÃÀåÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¹× ÇコÄÉ¾î ¿ëµµ¿¡¼­ »ç¿ëµÇ´Â »óÈ£ ¿¬°á ÀåÄ¡¸¦ Æ÷ÇÔÇÑ ÀÇ·á »ç¹° ÀÎÅͳÝ(IoMT)ÀÇ Àαâ Áõ°¡´Â ¾ÕÀ¸·Î ¼ö³â¿¡ °ÉÃÄ MLCC¿¡ ¼ö¸¹Àº ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. (1)
  • COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È ¼¼°è ÇコÄɾî ÁöÃâÀº Å©°Ô ±ÞÁõÇßÀ¸¸ç 2020³â¿¡´Â ¼¼°è GDPÀÇ 10.8%¿¡ ÇØ´çÇÏ´Â 9Á¶ ´Þ·¯¿¡ À̸£·¶½À´Ï´Ù. ÁÖ¸ñÇÒ Á¡Àº ÀÌ ÁöÃâÀÇ ¹èºÐÀÌ ¼ÒµæÃþ¿¡ µû¶ó Å©°Ô ´Ù¸£´Ù´Â °ÍÀÔ´Ï´Ù. Á¤ºÎ ÁöÃâÀº 2020³â ÀÇ·áºñ Áõ°¡ÀÇ ÁÖ¿ä ¿äÀÎÀ̾ú½À´Ï´Ù. ¸ðµç ¼ÒµæÃþ¿¡¼­ 1Àδç Á¤ºÎ º¸°Ç ÁöÃâÀÌ Áõ°¡ÇÏ¿© Àü³âµµ ¼ºÀå·üÀ» ¿ôµ¹¾Ò½À´Ï´Ù. (2)
  • ÀÓ¹ÚÇÑ ÆÒµ¥¹Í ¹× ´ëÀçÇØ¿¡ ´ëÇÑ ÇコÄɾî Áغñ ż¼¸¦ °­È­Çϱâ À§ÇØ Á¶»ç, ±ä±Þ ´ëÀÀ ´É·Â ¹× °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á±â°üÀº °¡´ÉÇÑ °Ç°­ À§±â¸¦ °ü¸®ÇÏ°í ±× ¿µÇâÀ» ÁÙÀ̱â À§ÇØ Á¶»ç, ±ä±Þ ´ëÀÀ ÈÆ·Ã, ÀÎÇÁ¶ó °­È­ µî »çÀü ´ëÃ¥ÀÇ Çʿ伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù. ½Å¼ÓÇϰí È¿À²ÀûÀÎ ±ä±Þ ´ëÀÀÀ» È®º¸ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ´ëÇÑ ÀÇ·á ÁöÃâ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ±â¼ú ½ÃÀåÀÇ Àü·«Àû ÀûÀÀÀÌ ÀÇ·á±â±â¿ë MLCC ¼ö¿ä Áõ°­

  • 2020³â ¼¼°èÀÇ È÷¾î·¯ºí, ¼Õ¸ñ½Ã°è, ÆÈÂî ¹× ±âŸ ¿þ¾î·¯ºí ½ÃÀåÀº ÇöÀúÇÑ ±Þ¼ºÀåÀ» ÀÌ·ç¾ú°í, ÃâÇϾ×Àº 4¾ï 4,470¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç, Àü³â ´ëºñ 28.38%ÀÇ Å« ¼ºÀå·üÀ» º¸¿´½À´Ï´Ù. ±×·¯³ª 2021³â¿¡´Â Àü³â´ëºñ 19.99%·Î ¼ºÀå·üÀÌ µÐÈ­µÇ¾ú°í ±â¼¼´Â ´Ù¼Ò µÐÈ­µÇ¾ú½À´Ï´Ù. ±× °á°ú 2022³â¿¡´Â 7.7% °¨¼ÒÇßÀ¸³ª ÀÌ´Â ÁÖ·Î °Å½Ã°æÁ¦ Á¤¼¼°¡ ¾ö°ÝÇÏ¿© 2021³âÀÇ ¿¹¿ÜÀûÀÎ ½ÇÀû¿¡ ÇÊÀûÇÏ´Â ½ÇÀûÀ» ´Þ¼ºÇϱ⠾î·Á¿ü±â ¶§¹®ÀÔ´Ï´Ù.
  • ÀÌ·¯ÇÑ Ä§Ã¼´Â ½ÃÀå Æ÷È­¿¡ ºÎºÐÀûÀ¸·Î ±âÀÎÇÕ´Ï´Ù. ¿þ¾î·¯ºí µð¹ÙÀ̽º ºÎ¹®Àº Àü³âµµ¿¡ »ó´çÇÑ È®´ë¸¦ º¸¿´À¸¸ç »ó´ç¼öÀÇ ÀáÀç °í°´ÀÌ ÀÌ¹Ì ±×·¯ÇÑ µð¹ÙÀ̽º¸¦ äÅÃÇ߱⠶§¹®¿¡ ¼ö¿ä °¨¼Ò·Î À̾îÁ³½À´Ï´Ù. ¼ö¿ä¸¦ À¯¹ßÇÏ°í ±â¼¼¸¦ µÇã±â À§ÇØ º¥´õ´Â Àú°¡Çü ´ëüǰ Á¦°ø, ¸Å·ÂÀûÀÎ °Å·¡ Á¦¾È Á¦°ø, ´ëÃâ ¿É¼Ç Á¦°ø, ±¸µ¶ ¼­ºñ½º µµÀÔ µî Àü·«Àû ¼ö´ÜÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´Ù¾çÇÑ ±â´É ¼¼Æ®¿Í °¡°Ý´ëÀÇ Àåºñ¸¦ µµÀÔÇÏ¿© Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ´Ù¾çÈ­ÇÏ°í ±× ÁÖº¯¿¡ °ß°íÇÑ »ýŰ踦 ±¸ÃàÇϰí ÀÖ´Â ±â¾÷Àº ½ÃÀåÀÌ ¼ºÀå ±Ëµµ¸¦ µÇãÀº ÈÄ º¸»óÀ» ¾ò´Â ÀÔÀå¿¡ ÀÖ½À´Ï´Ù.

ÀÇ·á±â±â¿ë MLCC ¾÷°è °³¿ä

ÀÇ·á±â±â¿ë MLCC ½ÃÀåÀº Àû´çÈ÷ ÅëÇÕµÇ¾î »óÀ§ 5°³»ç¿¡¼­ 57.03%¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù. Kyocera AVX Components Corporation(Kyocera Corporation), Murata Manufacturing, Samsung Electro-Mechanics, Taiyo Yuden ¹× Yageo Corporation(¾ËÆÄºª¼ø Á¤·Ä).

±âŸ ÇýÅÃ

  • ¿¢¼¿ Çü½Ä ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® ¼­Æ÷Æ®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à ¹× ÁÖ¿ä Á¶»ç °á°ú

Á¦2Àå º¸°í¼­ Á¦¾È

Á¦3Àå ¼­¹®

  • Á¶»ç ÀüÁ¦Á¶°Ç ¹× ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý

Á¦4Àå ÁÖ¿ä »ê¾÷ µ¿Çâ

  • ÇコÄɾî ÁöÃâ
    • ¼¼°èÀÇ ÀÇ·áºñ
  • ÀÇ·á±â±â µµÀÔ·ü
    • ¼¼°è ÀÇ·á±â±â º¸±Þ·ü
  • ¿þ¾î·¯ºí ÆÇ¸Å
    • ¼¼°èÀÇ ÀÇ·á¿ë ¿þ¾î·¯ºí ÆÇ¸Å ´ë¼ö
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ¹ë·ùüÀÎ ¹× À¯Åëä³Î ºÐ¼®

Á¦5Àå ½ÃÀå ¼¼ºÐÈ­

  • ÄÉÀ̽º »çÀÌÁ
    • 0 402
    • 0 603
    • 0 805
    • 1 206
    • 1 210
    • ±âŸ
  • Àü¾Ðº°
    • 100V-500V
    • 500V ÀÌ»ó
    • 100V ¹Ì¸¸
  • Á¤Àü ¿ë·®º°
    • 10¥ìF-100¥ìF
    • 10¥ìF ¹Ì¸¸
    • 100¥ìF ÀÌ»ó
  • À¯Àü À¯Çüº°
    • Ŭ·¡½º 1
    • Ŭ·¡½º 2
  • Áö¿ªº°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • À¯·´
    • ºÏ¹Ì
    • ¼¼°è ±âŸ Áö¿ª

Á¦6Àå °æÀï ±¸µµ

  • ÁÖ¿ä Àü·« µ¿Çâ
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ »óȲ
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Kyocera AVX Components Corporation(Kyocera Corporation)
    • Maruwa Co ltd
    • Murata Manufacturing Co., Ltd
    • Nippon Chemi-Con Corporation
    • Samsung Electro-Mechanics
    • Samwha Capacitor Group
    • Taiyo Yuden Co., Ltd
    • TDK Corporation
    • Vishay Intertechnology Inc.
    • Walsin Technology Corporation
    • Yageo Corporation

Á¦7Àå CEO¿¡ ´ëÇÑ ÁÖ¿ä Àü·«Àû Áú¹®

Á¦8Àå ºÎ·Ï

  • ¼¼°è °³¿ä
    • °³¿ä
    • Porter's Five Forces ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©
    • ¼¼°è ¹ë·ùüÀÎ ºÐ¼®
    • ½ÃÀå ¿ªÇÐ(DROs)
  • Á¤º¸¿ø ¹× Âü°í¹®Çå
  • µµÇ¥ À϶÷
  • ÁÖ¿ä ÀλçÀÌÆ®
  • µ¥ÀÌÅÍ ÆÑ
  • ¿ë¾îÁý
AJY 25.04.14

The Medical Devices MLCC Market size is estimated at 1.14 billion USD in 2024, and is expected to reach 3.23 billion USD by 2029, growing at a CAGR of 23.06% during the forecast period (2024-2029).

Medical Devices MLCC - Market - IMG1

The influence of MLCCs in the evolving medical device landscape is growing

  • The global medical devices MLCC market is experiencing significant growth, driven by growing healthcare expenditure and demand for advanced medical devices. The market is segmented by case size, with key sizes offering distinct technological advancements and addressing specific medical needs.
  • Due to their compact size and high capacity, 0 402 MLCCs are critical components in cutting-edge medical devices. They play a pivotal role in managing chronic ailments, improving patients' well-being, and driving healthcare innovations. The increasing prevalence of chronic diseases like arthritis and cancer spurs the demand for 0 603 MLCCs. These components are essential in devices that carry out MRIs and CT scans for early detection and accurate diagnosis.
  • The emergence of AI-powered medical robots and wearable medical sensors drives demand for 0 805 MLCCs. These components power AI and robotic functionalities in medical devices, with surgical robots and rehabilitation robots leading the trend. The 1 206 MLCCs play a crucial role in AI-driven diagnostic tools and wearable medical sensors. As diseases like cancer and atrial fibrillation continue to become more prevalent, accurate and efficient diagnostics have become paramount.
  • In the process of addressing specific medical implant needs, 1 210 MLCCs align with the diverse landscape of medical implants driven by demographic shifts and aesthetic procedures. With the aging population and an increase in aesthetic surgeries, the demand for specialized medical implants is growing. The other case sizes segment addresses distinct device designs and spatial constraints, adapting to evolving medical technology.

Medical device innovations are fueling the growth of MLCCs across continents

  • Asia-Pacific emerged as a dynamic hub for the medical device industry, driven by substantial opportunities in healthcare markets. With a remarkable 60% share of the global heart disease burden, India aims to collaborate with Japan by investing USD 42 billion to establish medical equipment manufacturing capabilities. This partnership aligns with the utilization of MLCCs in producing advanced devices like patient monitors and cardiac catheters.
  • North America's healthcare landscape is marked by a high burden of chronic diseases like heart disease and stroke. MLCCs offer the capacity to create compact and reliable medical devices that cater to these challenges. With millions of Americans living with chronic diseases, the demand for medical solutions that integrate MLCCs has increased, emphasizing their crucial role in enhancing patient outcomes.
  • The European healthcare market, the largest in the region, is driven by the aging population and increasing chronic diseases. Wearable health devices equipped with MLCCs aid in managing conditions like diabetes and cardiovascular disorders. The demand for miniaturized components aligns with MLCCs' capabilities, facilitating their integration into wearable devices for power management and wireless connectivity.
  • The Rest of the World (RoW) encompassing the Middle East & Africa (MEA) presents opportunities and challenges. The MEA region shows substantial potential for medical devices and pharmaceuticals. The Middle East's healthcare sector is projected to reach a revenue of AED 408 billion by 2026, driven by investments in medical technology and pharmaceuticals. The demand for advanced medical devices, including those incorporating MLCCs, is surging, aligning with the region's healthcare expansion and focus on technology.

Global Medical Devices MLCC Market Trends

The increasing popularity of the Internet of Medical Things and technological advancements in devices are propelling healthcare spending

  • The healthcare industry is experiencing significant technological advancements, including the growing adoption of innovative and wearable devices, making it a promising market for MLCCs. The increasing popularity of the Internet of Medical Things (IoMT), which involves interconnected devices used in medical and healthcare applications, will create numerous opportunities for MLCCs over the coming years. [1]
  • During the COVID-19 pandemic, there was a substantial surge in global healthcare expenditure, which reached USD 9 trillion, equivalent to 10.8% of the global GDP, in 2020. Notably, the distribution of this expenditure varied significantly among different income groups. Government expenditure was the primary catalyst behind the overall rise in health spending in 2020. In all income groups, per capita government spending on health witnessed an upswing, surpassing the growth rate observed in previous years. [2]
  • To boost healthcare readiness for impending pandemics or health catastrophes, increased investments are being made in research, emergency response capabilities, and healthcare infrastructure. Governments and healthcare organizations recognize the necessity for proactive measures like research, emergency response training, and infrastructure enhancements to manage and lessen the effects of possible health crises. Ensuring prompt and efficient emergency responses has increased the demand for healthcare expenditure in these areas.

Strategic adaptions in the wearables technology market augmenting the demand for medical devices MLCCs

  • In 2020, the global market for hearables, watches, wristbands, and other wearables experienced a remarkable surge, with shipments reaching USD 444.7 million, representing a substantial growth rate of 28.38% compared to the previous year. However, the momentum slightly slowed down in 2021, as the growth rate moderated to 19.99% compared to the preceding year. Consequently, in 2022, the industry witnessed a decline of 7.7%, mainly driven by challenging macroeconomic conditions and the difficulty in achieving comparable results to the exceptional performance observed in 2021.
  • This decline can be partially attributed to market saturation, wherein the wearable device sector had witnessed substantial expansion in the prior years, leading to diminished demand as a significant number of potential customers had already adopted such devices. To stimulate demand and regain momentum, vendors are adopting strategic measures, such as offering lower-cost alternatives, introducing attractive trade-in offers, providing financing options, and implementing subscription services. Furthermore, companies that diversify their product portfolio by incorporating devices with varying feature sets and price points, while building a robust ecosystem around them, stand to reap rewards once the market regains its growth trajectory.

Medical Devices MLCC Industry Overview

The Medical Devices MLCC Market is moderately consolidated, with the top five companies occupying 57.03%. The major players in this market are Kyocera AVX Components Corporation (Kyocera Corporation), Murata Manufacturing Co., Ltd, Samsung Electro-Mechanics, Taiyo Yuden Co., Ltd and Yageo Corporation (sorted alphabetically).

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY & KEY FINDINGS

2 REPORT OFFERS

3 INTRODUCTION

  • 3.1 Study Assumptions & Market Definition
  • 3.2 Scope of the Study
  • 3.3 Research Methodology

4 KEY INDUSTRY TRENDS

  • 4.1 Healthcare Expenditure
    • 4.1.1 Global Health Care Expenditure
  • 4.2 Medical Devices Adoption Rate
    • 4.2.1 Global Medical Devices Adoption Rate
  • 4.3 Wearables Sales
    • 4.3.1 Global Medical Wearables Sales
  • 4.4 Regulatory Framework
  • 4.5 Value Chain & Distribution Channel Analysis

5 MARKET SEGMENTATION (includes market size in Value in USD and Volume, Forecasts up to 2029 and analysis of growth prospects)

  • 5.1 Case Size
    • 5.1.1 0 402
    • 5.1.2 0 603
    • 5.1.3 0 805
    • 5.1.4 1 206
    • 5.1.5 1 210
    • 5.1.6 Others
  • 5.2 Voltage
    • 5.2.1 100V to 500V
    • 5.2.2 Above 500V
    • 5.2.3 Less than 100V
  • 5.3 Capacitance
    • 5.3.1 10 μF to 100 μF
    • 5.3.2 Less than 10 μF
    • 5.3.3 More than 100 μF
  • 5.4 Dielectric Type
    • 5.4.1 Class 1
    • 5.4.2 Class 2
  • 5.5 Region
    • 5.5.1 Asia-Pacific
    • 5.5.2 Europe
    • 5.5.3 North America
    • 5.5.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Key Strategic Moves
  • 6.2 Market Share Analysis
  • 6.3 Company Landscape
  • 6.4 Company Profiles
    • 6.4.1 Kyocera AVX Components Corporation (Kyocera Corporation)
    • 6.4.2 Maruwa Co ltd
    • 6.4.3 Murata Manufacturing Co., Ltd
    • 6.4.4 Nippon Chemi-Con Corporation
    • 6.4.5 Samsung Electro-Mechanics
    • 6.4.6 Samwha Capacitor Group
    • 6.4.7 Taiyo Yuden Co., Ltd
    • 6.4.8 TDK Corporation
    • 6.4.9 Vishay Intertechnology Inc.
    • 6.4.10 Walsin Technology Corporation
    • 6.4.11 Yageo Corporation

7 KEY STRATEGIC QUESTIONS FOR MLCC CEOS

8 APPENDIX

  • 8.1 Global Overview
    • 8.1.1 Overview
    • 8.1.2 Porter's Five Forces Framework
    • 8.1.3 Global Value Chain Analysis
    • 8.1.4 Market Dynamics (DROs)
  • 8.2 Sources & References
  • 8.3 List of Tables & Figures
  • 8.4 Primary Insights
  • 8.5 Data Pack
  • 8.6 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦